Información del artículo
El Texto completo está disponible en PDF
Referencias bibliogréficas
[1.]
Aapro M.S..
Adjuvant Therapy of Primary Breast Cancer: A Review of Key Findings from the 7th International Conference, St Gallen, February 2001.
The Oncologist, 6 (2001), pp. 376-385
[2.]
International Union Against Cancer.
TNM Classification of Malignant Tumours.
Wiley-Liss, 5,
[3.]
Bach P.B., Cramer L.D., Schrag D., Downey R.J., Gelfand S.E., Begg C.B..
The influence of hospital volume on survival after resection for lung cancer.
N Engl J Med, 345 (2001), pp. 181-188
[4.]
Heald R.J..
Rectal cancer: the surgical options.
Eur J Cancer, 31 (1995), pp. 1189
[5.]
Fong Y..
Surgical therapy of hepatic colorectal metastasis.
CA Cancer J Clin, 49 (1999), pp. 231-255
[6.]
Hoskins W.J..
The influence of cytoreductive surgery on recurrence free interval and survival in small volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Gynecol Oncol, 47 (1992), pp. 159-165
[7.]
Flanigan R.C., Salmon S.E., Blumenstein B.A., Bearman S.I., Roy V., McGrath P.C., et al.
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.
N Eng J Med, 345 (2001), pp. 1655-1659
[8.]
Hellman S..
Principles of cancer management: radiation therapy.
Cancer. Principles & Practice of Oncology, 6, pp. 265-288
[9.]
Whelan T.J., Julian J., Wright J., Jadad R.A., Levine M.L..
Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis.
J Clin Oncol, 18 (2000), pp. 1220-1229
[10.]
Early Breast Cancer Trialists Collaborative Group.
Effects of radiotherapy and surgery in early breast cancer. An overview of the randomised trials.
N Engl J Med, 333 (1995), pp. 1444-1451
[11.]
Cunningham D., Pyrhönen S., James R.D., Punt CJA, Hickish T.F., Heikkila R., et al.
Randomised trial of irinotecan plus supportive care versus supportive care alone after failure for patients with metastatic colorectal cancer.
Lancet, 352 (1998), pp. 1413-1418
[12.]
Shepherd F.A., Dancey J., Ramlau R., Mattson K., Gralla R., O'Rourke M., et al.
Prospective randomised trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotheray.
J Clin Oncol, 18 (2000), pp. 2095-2103
[13.]
Early Breast Cancer Trialists Collaborative Group.
Tamoxifen for early breast cancer: an overview of the randomised trials.
Lancet, 352 (1998), pp. 930-936
[14.]
Kirkwood J.M., Strawderman M.H., Ernstoff M.S., Smith T.J., Borden E.C., Blum R.H..
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.
J Clin Oncol, 14 (1996), pp. 7-17
[15.]
Baselga J., Tripathy D., Mendelsohn J., Baughman S., Benz C.C., Dantis L., et al.
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatis breast cáncer.
Semin Oncol, 26 (1999), pp. 78-83
[16.]
McLaughlin P., Grillo-López A.J., Link B.K., Levy R., Czuczman M.S., Williams M.E., et al.
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
J Clin Oncol, 16 (1998), pp. 2825-2833
Copyright © 2003. Academia de Ciencias Médicas de Bilbao